Thrombosis, a major cause of deaths in this modern era responsible for 31% of all global
deaths reported by WHO in 2017, is due to the aggregation of fibrin in blood vessels which …

Biopharmaceuticals is a rapidly emerging field that explores and employs biological
organisms and their products for therapeutic applications. Enzymes are remarkable …

Enzyme therapies are attracting significant attention as thrombolytic drugs during the current
scenario owing to their great affinity, specificity, catalytic activity, and stability. Among various …

The development of safe and efficacious enzyme-based human therapies has increased
greatly in the last decades, thanks to remarkable advances in the understanding of the …

Background Time to reperfusion is the key to the treatment of patients with ST-elevation
myocardial infarction (STEMI). It is uncertain whether adjunctive thrombolytic therapy …

Staphylococcus aureus represents a notorious opportunistic pathogen causing various
infections in biofilm nature, imposing remarkable therapeutic challenges worldwide. The …

Smart carrier-based immobilization has widened the use of enzymes for the treatment of
several disorders. Large surface areas, tunable morphology, and surface modification ability …

In the realm of thrombosis treatment, bioengineered outer membrane vesicles (OMVs) offer
a novel and promising approach, as they have rich content of bacterial‐derived components …

Thrombolytic therapy is one of the most effective treatments for thrombus dissolution and
recanalization of blocked vessels in thrombotic diseases. However, the application of the …

Although seaweeds have been used for decades as food, medicinal plants, and nutritional
supplements, their use as a vaccine production and delivery platform has been barely …